These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 888484)

  • 1. [Clinical problems in the application of sedatives in patients with chronic liver disease (author's transl)].
    Becker K
    Z Gastroenterol; 1977 Jun; 15(6):356-61. PubMed ID: 888484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition and effects of sedatives and analgesics in liver disease.
    Hoyampa AM; Branch RA; Schenker S
    Annu Rev Med; 1978; 29():205-18. PubMed ID: 348033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypnotics and sedatives in liver diseases (summary of session 4)].
    Z Gastroenterol Verh; 1976; (12):203-20. PubMed ID: 73293
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sedatives and liver diseases].
    Franken FH
    Minerva Med; 1973; 64(49):2619-21. PubMed ID: 4727522
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics.
    Schenker S; Hoyumpa AM; Wilkinson GR
    Med Clin North Am; 1975 Jul; 59(4):887-96. PubMed ID: 238085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical pharmacology of narcotics and sedatives].
    Lange G
    Z Allgemeinmed; 1971 Dec; 47(35):1846-52. PubMed ID: 4332993
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy in liver diseases: problems in intensive care].
    Follath F
    Schweiz Med Wochenschr; 1986 Apr; 116(17):549-52. PubMed ID: 3715434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major drug interactions: effect of liver disease, alcohol, and malnutrition.
    Hoyumpa AM; Schenker S
    Annu Rev Med; 1982; 33():113-49. PubMed ID: 7044269
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolism of hypnotic and sedative drugs in cholestasis (author's transl)].
    Denk H
    Z Gastroenterol; 1977 Jun; 15(6):373-7. PubMed ID: 888486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver function reserve in surgical treatment of patients with portal hypertension: report of 146 cases.
    Gu DY; Xu WG; Lin ZP; Luo Z; Wu HF
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):515-8. PubMed ID: 14607677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative clinical evaluation of lorazepam (author's transl)].
    Padron C
    Schweiz Rundsch Med Prax; 1974 Apr; 63(16):494-6. PubMed ID: 4597377
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic encephalopathy: current status.
    Schenker S; Breen KJ; Hoyumpa AM
    Gastroenterology; 1974 Jan; 66(1):121-51. PubMed ID: 4588556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of aminoacid and protein metabolism disturbances in liver disease (author's transl)].
    Gerok W
    Leber Magen Darm; 1981 Apr; 11(2):63-72. PubMed ID: 6785546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sedation in liver diseases].
    Markoff N
    Hippokrates; 1974 Nov; 45(4):519-21. PubMed ID: 4465362
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatic sarcoidosis with portal hypertension and liver failure. Report of a case and review of the literature (author's transl)].
    Buffet C; Martin E; Imbert MC; Chousterman M; Labayle D; Etienne JP
    Gastroenterol Clin Biol; 1977; 1(8-9):671-80. PubMed ID: 913966
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescribing for patients with liver damage.
    Drug Ther Bull; 1970 Nov; 8(24):93-4. PubMed ID: 5491958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interdisciplinary management of portal hypertension: status of portosystemic shunt operations].
    Häring R
    Zentralbl Chir; 1995; 120(2):95-102. PubMed ID: 7709669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward safer sedation in patients with cirrhosis: have we done enough?
    Thuluvath PJ
    Gastrointest Endosc; 2009 Aug; 70(2):269-71. PubMed ID: 19631803
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug prescribing in hepatobiliary disease.
    Roberts RK; Desmond PV; Schenker S
    Drugs; 1979 Mar; 17(3):198-212. PubMed ID: 378647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.